PAthwAy of Dyspneic patIent in Emergency in France

NCT ID: NCT06509854

Last Updated: 2024-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

89700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-30

Study Completion Date

2031-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men/women), age categories, mode of admission, and comorbidities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Dyspnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or women aged 18 years and older.
* Patients with acute dyspnea managed by a medical emergency team at the investigator centers between 2010 and 2021.

Exclusion Criteria

\- Cardiorespiratory arrest before emergency department management.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pr. Nicolas GIRERD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pr. Nicolas GIRERD

Clinical Professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tahar CHOUIHED, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Central Hospital, Nancy, France

Nicolas GIRERD, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CHRU de Nancy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Besançon

Besançon, , France

Site Status

CHU de Dijon

Dijon, , France

Site Status

Hospices civils de Lyon, Groupement Hospitalier Édouard-Herriot

Lyon, , France

Site Status

CHRU of Nancy

Nancy, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicolas GIRERD, MD, PhD

Role: CONTACT

+33383157322

Tahar CHOUIHED, MD, PhD

Role: CONTACT

+33383157322

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Omide TAHERI

Role: primary

Patrick RAY, MD, PhD

Role: primary

Stephanie BOSNE, MD

Role: primary

Tahar CHOUIHED

Role: primary

+33383157322

Nicolas GIRERD

Role: backup

0383157322

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022PI21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.